Eli Lilly invests additional $450M to expand RTP manufacturing site

Eli Lilly announced a $450 million investment to expand its Research Triangle Park facility in North Carolina, adding parenteral filling, device assembly and packaging capacity for incretin diabetes drugs. The expansion will create at least 100 jobs and is expected to be fully operational in 2027.

“Expanding our operations at Research Triangle Park will accelerate the rate at which we can produce medicines that patients rely on to address serious health challenges like diabetes.”prnewswire.com

• 2 sources
• prnewswire.comLilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle ParkEli Lilly, CompanyJan 24, 2023
• ncbiotech.orgLilly Adds $450M, 100+-Job Expansion to RTP ...Jan 24, 2023

Summarized from public sources; check the original articles before acting on it.